Skip to main content
Clinical Trials/NCT05029323
NCT05029323UnknownNot Applicable

Validation of a Novel Simplified Head up Tilt Test (HUTT) Protocol Versus the Conventional Protocol

University of Campania "Luigi Vanvitelli"1 site in 1 country500 target enrollmentStarted: January 7, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
500
Locations
1
Primary Endpoint
HUTT positivity rate during passive phase

Study Overview

Brief Summary

The purpose of the study is to compare the positivity rate associated with a novel simplified Tilt-Table (TT) test protocol versus the conventional TT protocol

Detailed Description

All patients with unexplained syncope at initial evaluation with indication to perform a Head up tilt test (HUTT) will be randomized to "conventional" HUTT protocol or "fast" HUTT protocol characterized by a stabilization phase of 5 min in the supine position; a passive phase of 10 min at a tilt angle of 60 degrees; a provocation phase of further 10 min after 300 micrograms NTG sublingual spray. The novel simplified "fast" HUTT protocol has been designed to provide non inferior positivity rates as compared with the conventional protocol in the selected population.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
Single (Participant)

Eligibility Criteria

Ages
14 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •All patients with unexplained syncope at initial evaluation and indication to perform HUTT

Exclusion Criteria

  • •No informed consent
  • •PM/ICD device recipients

Arms & Interventions

Conventional HUTT

Active Comparator

All patients with unexplained syncope at initial evaluation with indication to perform a Head up tilt test (HUTT) randomized to "conventional" HUTT protocol characterized by a stabilization phase of 5 min in the supine position; a passive phase of 10 min at a tilt angle of 60 degrees; aprovocation phase of further 10 min after 300 micrograms NTG sublingual spray.

Intervention: Conventional HUTT (Diagnostic Test)

Fast HUTT

Experimental

All patients with unexplained syncope at initial evaluation with indication to perform a Head up tilt test (HUTT) randomized to "fast" HUTT protocol characterized by a stabilization phase of 5 min in the supine position; a passive phase of 10 min at a tilt angle of 60 degrees; a provocation phase of further 10 min after 300 micrograms NTG sublingual spray.

Intervention: Fast HUTT (Diagnostic Test)

Outcomes

Primary Outcomes

HUTT positivity rate during passive phase

Time Frame: through study completion, an average of 1 year

The study endpoint is the number of patients who experienced syncope during the passive phase of HUTT.

HUTT positivity rate during active phase

Time Frame: through study completion, an average of 1 year

The study endpoint is the number of patients who experienced syncope during the active phase of HUTT.

Secondary Outcomes

  • The type of HUTT-induced syncope during passive phase(through study completion, an average of 1 year)
  • The type of HUTT-induced syncope during active phase(through study completion, an average of 1 year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Vincenzo Russo

Principal Investigator

University of Campania "Luigi Vanvitelli"

Study Sites (1)

Loading locations...

Similar Trials